New Vaccine Protects Against Streptococcus pyogenes Infections
Author Information
Author(s): Ulrich Robert G
Primary Institution: Army Medical Research Institute of Infectious Diseases
Hypothesis
Can a recombinant protein vaccine protect against Streptococcus pyogenes sepsis and toxic shock?
Conclusion
The genetically attenuated SpeA-SpeB fusion protein may be effective in controlling S. pyogenes infections.
Supporting Evidence
- Vaccination with the SpeA-SpeB fusion protein protected mice from lethal S. pyogenes infection.
- High antibody titers were produced in vaccinated mice.
- Vaccination resulted in seroconversion after the first dose with the fusion protein.
Takeaway
Researchers created a new vaccine that helps mice fight off a dangerous bacteria called Streptococcus pyogenes, which can make people very sick.
Methodology
The study involved cloning genes for two proteins, SpeA and SpeB, and testing a fusion protein in HLA-DQ8 transgenic mice.
Limitations
The study's results may not fully translate to humans due to the use of a mouse model.
Participant Demographics
HLA-DQ8 transgenic mice were used in the study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website